GMG says U.S. EPA approval opens the door to graphene coating sales in North America

Graphene Manufacturing Group said on March 31, 2026, that its THERMAL-XR graphene coating has received U.S. EPA approval, clearing a regulatory hurdle the company had been working toward for years and giving it a path into the North American HVAC-R market.

Main Development

The company said the approval applies to THERMAL-XR, its graphene-based coating product, and that the clearance is an important step because it allows the product to be sold in the United States through distributor Nu-Calgon. GMG said the partner provides access to about 4,000 distribution points across North America.

That matters because the approval shifts THERMAL-XR from a product in development and limited rollout toward a more formal commercial push in a large, established market. GMG framed the milestone as one of the few graphene approvals of its kind in the United States.

Strategic Importance

For GMG, the timing is significant. The company said it is also building out European sales efforts, creating a multi-channel push that could support near-term revenue growth if adoption follows. In its March 31 interview with Proactive, CEO Craig Nicol said the company expects early revenues this year, although scaling will depend on customer uptake and distributor performance.

The U.S. HVAC-R market is a practical target for a coating product because it gives the company a route to commercial use in existing maintenance and retrofit workflows rather than waiting on entirely new infrastructure or consumer behavior.

Consumer Impact

For end users, the immediate relevance is less about graphene as a research material and more about whether THERMAL-XR can win adoption as a performance coating in air conditioning and related systems. If the company converts the regulatory approval into sales, the product could gain traction in commercial and industrial maintenance settings where efficiency and corrosion protection are central buying criteria.

What Comes Next

The next test is execution: distributor rollouts, customer trials and repeat orders. GMG has tied its near-term growth case to those commercial steps, with North American and European expansion now carrying the burden of turning approval into revenue.